磷霉素在耐药形势下的临床应用定位再评估
作者:
作者单位:

作者简介:

杨晶

通讯作者:

中图分类号:

R969.3

基金项目:

天津市应用基础与前沿技术研究计划(15JCQNJC11500)


Re-assessment of clinical application of fosfomycin under drug-resistant situation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    磷霉素是一种发现较早的天然抗生素,具有独特的抗菌作用机制,通过阻断细菌细胞壁合成的第一步,可以作用于革兰阳性菌和革兰阴性菌,是一种繁殖期快速杀菌剂,并且能够破坏细菌生物被膜或抑制其形成。近年来,在严峻的耐药形势下,磷霉素凭借其独特的抗菌作用机制、药代动力学特点及交叉耐药发生低等优势,成为被广泛研究和应用的抗生素,尤其是对于多重耐药菌,磷霉素作为重要的联合应用药物,临床应用定位越来越广泛。

    Abstract:

    Fosfomycin is an early discovered natural antibiotic with unique antimicrobial mechanism, by blocking the first step in the synthesis of bacterial cell wall, it can act on gram-positive bacteria and gram-negative bacteria, and is a rapid bactericide in reproductive period of bacteria and can destroy or inhibit formation of bacterial biofilm. In recent years, under the current severe drug resistance situation, fosfomycin has become a widely studied and applied antibiotic because of its unique antimicrobial mechanism, pharmacokinetic characteristics and low cross-resis-tance, especially for multidrug-resistant organisms, as an important combined used antibiotic, fosfomycin has been applied more and more widely in clinical practice.

    参考文献
    相似文献
引用本文

杨晶.磷霉素在耐药形势下的临床应用定位再评估[J]. 中国感染控制杂志,2019,18(7):690-695. DOI:10.12138/j. issn.1671-9638.20194416.
YANG Jing. Re-assessment of clinical application of fosfomycin under drug-resistant situation[J]. Chin J Infect Control, 2019,18(7):690-695. DOI:10.12138/j. issn.1671-9638.20194416.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-11-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-07-28
  • 出版日期: